Associated Papers
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Kuras M et al.
Cancers, 2025
40075679 (PubMed )
Supplement: cancers-17-00832-s001.zip › Table_S5._SAAVs.xlsx › Table_S5A
ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation.
Enyedi EE et al.
Biomedicines, 2024
38790902 (PubMed )
Supplement: biomedicines-12-00940-s001.zip › biomedicines-2930173-supplementary.pdf
MAVS Genetic Variation Is Associated with Decreased HIV-1 Replication In Vitro and Reduced CD4+ T Cell Infection in HIV-1-Infected Individuals.
Stunnenberg M et al.
Viruses, 2020
IPS-1 polymorphisms in regulating interferon response in HBV infection.
Liu K et al.
Bioscience Trends, 2019
MAVS is not a Likely Susceptibility Locus for Addison's Disease and Type 1 Diabetes.
Zurawek M et al.
Archivum Immunologiae Et Therapiae Experimentalis, 2017
Alteration of Antiviral Signalling by Single Nucleotide Polymorphisms (SNPs) of Mitochondrial Antiviral Signalling Protein (MAVS).
Xing F et al.
Plos One, 2016
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.
Hoffmann FS et al.
Hepatology (baltimore, Md.), 2015
The genetics of innate immunity sensors and human disease.
Pothlichet J et al.
International Reviews of Immunology, 2013
A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.
Pothlichet J et al.
Embo Molecular Medicine, 2011
Select a paper to view details